# Clearwater Paper Corporation (CLW) — Equity Research | October 27, 2026

**Rating: Buy — High Risk.** Clearwater Paper is an interesting, deeply cyclical turnaround with meaningful upside if paperboard pricing recovers. However, its earnings have collapsed, a major acquired mill needs remediation, and near-term cash generation is weak.

At the October 27 regular-session close of **$13.69**, my probability-weighted fair value is **$18.70**, implying **36.6% potential upside**. The stock fell approximately 28.8% following the October 26 earnings release. The price reset is substantial, but the problems behind it are real.

**The stock looks attractive enough for a speculative Buy at $13.69, but not for a high-conviction investment.** The downside is unusually severe if the industry recovery stalls.

## Company & Research Metadata

- **Company:** Clearwater Paper Corporation
- **Ticker:** CLW
- **Exchange:** NYSE
- **Sector / Industry:** Materials / Paperboard packaging manufacturing
- **Template version:** 2.7
- **Research date:** 2026-10-27
- **Valuation / score price snapshot:** $13.40 — 2026-11-03 regular-session close, America/New_York
- **Price snapshot time / timezone:** Regular-session close, America/New_York (including exchange half-days)
- **Price snapshot date:** 2026-11-03
- **Tracking tier:** On the Radar
- **Owned:** No
- **Primary operating period reviewed:** Q3 2026 and nine months ended September 30, 2026
- **Historical period reviewed:** FY2023–FY2025 and 9M 2026, with continuing-operation and discontinued-operation comparability qualifications
- **Latest investor presentation reviewed:** Clearwater Paper June 2026 Investor Presentation, supplemented by Q3 2026 earnings remarks
- **Latest earnings call reviewed:** Q3 2026 earnings call and complete material Q&A, October 26, 2026
- **Latest post-earnings management commentary reviewed:** Q3 2026 earnings release and call, October 26, 2026
- **Opportunity Rank:** #36 of 76
- **Competitor / analyst-Q&A audit:** 2026-10-28; original operating, price and valuation snapshots retained.

## What's Changed Since Previous Review

**Current Review:** 2026-10-28

**Previous Review:** 2026-10-27

**Update Trigger:** Competitor relevance and analyst-Q&A correction

| Area | Previous View | Current View | Investment Impact |
|---|---|---|---|
| Competition | Preceding operating and comparable-company classifications | Product/customer/geographic boundaries corrected; direct rivals separated from substitutes, partners and valuation anchors | Corrects the competitive comparison; does not by itself re-underwrite the valuation |
| Analyst questions | Prior source-linked Q&A summaries | Complete questions and sentence-form management answers; all 4 existing rows retained | Improves readability while preserving the recorded exchange meaning |
| Valuation and scores | Approved operating/price snapshots, scenarios, scores and decisions | Preserved | No price refresh, rerank or change to valuation assumptions in this correction pass |

**Thesis:** No new fundamental thesis determination is made in this correction pass. The prior investment decision is preserved; the corrected competitive scope should govern the next substantive review.

## Investment Snapshot

| Metric | Current View |
|---|---|
| Price Snapshot | $13.40 — 2026-11-03 regular-session close, America/New_York |
| Rating / Zone Status | Buy |
| Bear / Base / Bull Fair Value | $2.50 / $19.00 / $42.25 |
| Scenario Probabilities | 30% / 50% / 20% |
| Probability-Weighted Fair Value | **$18.70** |
| Probability-Weighted Expected Return | +39.6% |
| Bear-Case Return | -81.3% |
| Strong Buy Zone | ≤ $2.75 |
| Buy Zone | > $2.75 to $14.96 |
| Hold / Watch Zone | > $14.96 to $20.78 |
| Avoid Chasing Above | $20.78 |
| Quality Score / Tier | 50.4 / C |
| Opportunity Score / Rank | 55.4 / #36 of 76 |
| Risk Level | High; valuation confidence 35/100 |
| Tracking / Ownership | On the Radar / No recorded position |

**Decision rationale:** CLW offers meaningful upside if paperboard pricing and operating performance normalize. Its reported earnings and free cash flow do not currently support a strong quality rating, and Augusta remediation remains uncertain. I would treat it as a small, speculative turnaround position rather than a core compounder.

## Investment Thesis

CLW is primarily a bet on three things:

1. A recovery in North American paperboard pricing.
2. Fixing operational problems at its Augusta mill.
3. Converting improved earnings into free cash flow instead of spending the recovery on maintenance and repairs.

The business has substantial operating leverage. Its mills have high fixed costs, so modest changes in selling prices can produce disproportionately large changes in profits. At approximately 1.25 million tons of annual shipments, a $10-per-ton pricing change represents roughly $12.5 million in annual revenue. Much of an increase can flow into EBITDA if production costs and volumes remain stable. That is meaningful for a company currently valued at only $221 million in the equity market.

However, the opposite also applies. Pricing declines can quickly eliminate profits.

The business is a meaningful independent supplier of premium bleached paperboard in North America. Management says a fully realized $60-per-ton price increase could contribute over $70 million to annual EBITDA—enormous relative to CLW's current equity value. A recently completed refinancing extended major debt maturities to 2031, giving the turnaround more time. The shares trade at approximately 0.28 times book value, although the assets are specialized mills whose realizable value is far less certain than their accounting value.

### What the Market May Be Mispricing

The bullish possibility is that investors are extrapolating unusually poor 2026 earnings into the future.

The bearish possibility is that the company's structural economics are worse than management expected following the Augusta acquisition.

My view is that **the cyclical recovery opportunity is credible, but the Augusta execution risk deserves a substantial valuation discount.** The market may be too pessimistic, but it is not irrationally pessimistic.

## Business Overview

Clearwater manufactures paperboard used by other companies to produce consumer packaging. It does not primarily sell finished packaging to consumers.

Its customers are packaging converters that buy large paperboard rolls or sheets, then cut, print, fold, and transform them into finished packaging. Its products become folding cartons, food-service packaging, and other consumer packaging.

| Product | Applications | Economics |
|---|---|---|
| Solid Bleached Sulfate (SBS) | Premium cartons, food packaging, cups, plates | Core business; higher quality but cyclical |
| Market pulp | External industrial customers | Smaller complementary revenue stream |
| Coated Recycled Board (CRB) | Cost-sensitive consumer packaging | New offering through Greenpaper partnership |
| Coated Unbleached Kraft (CUK) | Beverage carriers and folding cartons | Planned expansion using existing capacity |

The company's SBS portfolio benefits from clean white surfaces, consistent quality, strength, and printability. These attributes are particularly important for pharmaceutical, cosmetics, food-service, and premium consumer applications.

Clearwater has three primary mills: Lewiston, Idaho; Cypress Bend, Arkansas; and Augusta, Georgia. Together they have approximately 1.4 million tons of annual SBS capacity across five paper machines. Over 90% of pulp requirements are supported by integrated production. That reduces dependence on external pulp suppliers, although wood fiber, chemicals, energy, freight, and labor remain substantial cost drivers.

In 2024, Clearwater fundamentally changed its business:

| Transaction | Consideration | Strategic consequence |
|---|---:|---|
| Acquired Augusta paperboard operations from Graphic Packaging | ~$711M | Expanded capacity and national footprint |
| Sold consumer tissue business to Sofidel | ~$1.06B gross proceeds | Became a focused paperboard supplier |

The rationale was reasonable: concentrate on packaging and build scale as an independent supplier. But the timing was unfortunate. Industry prices subsequently weakened, while Augusta encountered asset reliability and performance problems. The transformation increased CLW's sensitivity to the paperboard cycle and removed the diversification previously provided by tissue.

### Business Takeaway

Clearwater's economic engine is converting a capital-intensive and largely fixed-cost mill network into premium paperboard supplied to independent converters. Realized price per ton, capacity utilization, and maintenance reliability matter more than headline revenue growth.

## Industry, TAM & Market Share

Management estimates total North American paperboard supply at approximately 10–11 million tons, with long-run demand growth around 1–2% annually. Its June 2026 presentation estimates approximately 5.7 million tons of SBS, 2.9 million tons of CRB, and 2.2 million tons of CUK capacity.

Within SBS, CLW's 1.4 million tons of capacity represents approximately 25% of the stated 5.7-million-ton industry capacity. This is a capacity-based calculation, not verified shipment market share. Separately, the company estimated around 11% of total North American paperboard capacity in 2025. These definitions should not be conflated.

A consistent competitor-by-competitor market-share dataset was not available, so I would not assign precise shares to other producers.

The industry's biggest problem has been capacity additions running ahead of demand. In 2025, approximately 500,000 tons of new North American SBS capacity came online. Management now estimates significant production curtailments and closures, improving industry utilization. That could be the beginning of the next upcycle. However, European imports remain more resilient than management had anticipated.

The packaging market is durable but relatively mature. Sustainability trends, premium printing, and substitution away from some plastics may support demand. Yet the underlying market does not have a particularly high structural growth rate.

### Market-Share Analysis

#### Competitive Scale / Position

| Company / Platform | Primary Position | Relative Scale | Growth Direction | Investment Relevance |
|---|---|---|---|---|
| CLW | Independent premium SBS producer | ~1.4M tons annual SBS capacity | Volumes resilient, pricing depressed | High direct exposure to SBS recovery |
| Graphic Packaging | Integrated board and consumer packaging | Much larger diversified manufacturer | Cyclical packaging exposure | Integration and scale advantage; channel conflict for independent converters |
| Smurfit Westrock | Global integrated packaging | Much larger global footprint | Diversified industrial packaging | Strong capital resources and global scale |
| Georgia-Pacific | Diversified paper and packaging | Large private producer | Not consistently quantifiable | Strong supply-side competitor |
| Sappi and European FBB suppliers | Specialty/imported paperboard alternatives | International production | Imports resilient despite tariffs | Limits North American price recovery |

### Industry Takeaway

I would value CLW primarily on sustainable margins and cash generation—not on an aggressive TAM expansion narrative. Improving utilization and pricing could be powerful catalysts, but industry supply remains a major swing factor.

## Customer Economics

Clearwater's independence is its most distinctive competitive attribute. Large integrated packaging manufacturers often manufacture paperboard and convert it into finished packaging themselves. That means they may compete with their own converter customers. Clearwater supplies independent converters without that same channel conflict.

This can be particularly attractive to small and midsize converters that want reliable supply from a partner that does not compete directly with them.

In 2025, the 10 largest customers accounted for 46% of revenue. Approximately 49% of customer agreements had pricing tied to third-party industry indices. Customer contracts generally lacked guaranteed minimum purchase volumes. This limits CLW's ability to control realized prices or ensure capacity utilization during weak markets.

CLW's most relevant customer-economics proxies are selling price per ton, volume committed versus merely ordered, mill loading, input cost per ton, freight efficiency, and the lag between published price increases and contract realization. Traditional software-style retention and acquisition-cost metrics would not be useful here.

### Customer-Economics Takeaway

Incremental pricing and production can generate attractive contribution margins because fixed manufacturing costs are already present. But customers have negotiating leverage, contract pricing lags, and no guaranteed minimum purchases, so the incremental economics are volatile.

## Competitive Landscape & Moat

### Competitive Landscape

| Competitor | Market Share | Positioning | Advantages vs. Company | Disadvantages vs. Company | Current Direction |
|---|---|---|---|---|---|
| Graphic Packaging (GPK) | Not comparably verified | Direct segment: paperboard mills supplying relevant packaging substrates | Scale, customer relationships, converting integration | Competes with some converter customers | Exposed to industry cycle |
| Smurfit Westrock (SW) | Not comparably verified | Direct segment: North American consumer paperboard; not all corrugated packaging | Scale, diversification, distribution | Less focused on independent SBS converters | Broad cyclical exposure |
| Georgia-Pacific | Not comparably verified | Direct segment: paperboard, not unrelated tissue products | Scale and financial resources | Less independent-channel focus | Significant competitive incumbent |
| Sappi | Not comparably verified | Direct segment: competing specialty paperboard grades | International reach, product range | Less concentrated North American SBS service | Imports competitive |
| European FBB producers | Not comparably verified | Substitute: FBB imports where converters can replace SBS | Product and price alternatives | Freight and tariff exposure | Imports proving resilient |

### Moat Assessment

**Moat direction: Stable. Moat strength: Limited to Moderate.**

Clearwater has a real commercial niche built on independence, product quality, and service. Its geographically distributed facilities also help reduce delivery distances. But I do not consider this a strong economic moat.

Customers can switch suppliers, pricing is heavily influenced by industry conditions, and larger competitors have more financial resources. The independence advantage is valuable, but not strong enough to prevent severe earnings cyclicality.

### Competitive Takeaway

Clearwater is structurally stronger in serving independent converters without channel conflict. It is weaker than larger competitors in scale, diversification, and ability to absorb prolonged downcycles. Its niche is defensible, but profitability remains cyclical rather than protected.

## Financial Profile

### Historical Financials

Financial reporting periods follow the issuer's fiscal year: completed FY rows plus standalone current-year quarters and cumulative H1/9M for FY2026. Revenue, FCF and SBC are flows; cash is a period-end balance. FCF = operating cash flow minus property/equipment capex from SEC company facts; quarterly FCF after Q1 and any quarterly SBC derived from YTD are visibly marked. Missing values are N/D, not zero. Unit: USD millions. Data extracted from SEC-tagged filings as of 2026-11-07. Company-specific FCF definitions and acquisition effects may require further reconciliation.

| Period | Revenue | Growth | Gross Margin | Operating Margin | FCF | FCF Margin | SBC | Diluted Shares | Cash | Debt |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| FY2023 | $1,136 | — | 17.7% | 6.9% | $117.0 | 10.3% | $9.9 | — | — | — |
| FY2024 | $1,384 | +21.8% | 5.5% | −4.7% | −$55.2 | −4.0% | $5.6 | — | — | — |
| FY2025 | $1,555 | +12.4% | 7.4% | −2.7% | −$76.5 | −4.9% | $3.8 | ~16.17M | $30.7 | ~$346.1 |
| Q1 FY2026 | $360.3 | N/D | N/D | -2.9% | −$8.6 (derived: CFO - capex) | -2.4% | $0.6 | 16.08 | $36.5 | N/D |
| Q2 FY2026 | $374.8 | N/D | N/D | -6.4% | $59.4 (derived: current YTD - prior YTD) | 15.8% | $1.7 | 16.126 | $95.4 | N/D |
| H1 FY2026 | $735.1 | N/D | N/D | -4.7% | $50.8 (derived: CFO - capex) | 6.9% | $2.4 | 16.09 | $95.4 | N/D |
| Q3 FY2026 | $384.9 | N/D | N/D | 0.6% | $15.9 (derived: current YTD - prior YTD) | 4.1% | $2.6 | 16.134 | $35.7 | N/D |
| 9M FY2026 | $1,120 | N/D | N/D | -2.8% | $66.7 (derived: CFO - capex) | 6.0% | $5 | 16.105 | $35.7 | N/D |

#### Supplemental historical reporting context (retained)

#### Supplemental historical reporting context (retained)

#### Supplemental historical reporting context (retained)

Historical net cash flow is distorted by the tissue sale and major transactions. At September 30, 2026, gross debt and restricted cash temporarily included old notes and their redemption funding; debt shown here is approximate post-redemption economic gross debt. The company's reported economic net debt was **$260.7M**.

Adjusted EBITDA from continuing operations: FY2023 **$122.0M**, FY2024 **$36.0M**, FY2025 **$107.2M**, and 9M 2026 **$18.0M**. Margins were 10.7%, 2.6%, 6.9%, and 1.6%, respectively.

Latest Q3 2026 results:

| Metric | Q3 2025 | Q3 2026 | Change |
|---|---:|---:|---:|
| Revenue | $399M | $385M | −3.5% |
| Paperboard shipments | 324K tons | 322K tons | −0.6% |
| Selling price | $1,160/ton | $1,111/ton | −4.2% |
| Adjusted EBITDA | $17.8M | $24.4M | +37.1% |
| Net income | −$53.3M | −$1.6M | Improved |

At first glance, Q3 looks encouraging. However, EBITDA benefited from maintenance timing and approximately $9.5 million of insurance recoveries allocated against Augusta disruptions. The improvement is therefore not a clean indication of normalized profitability.

Management guided Q4 adjusted EBITDA to just $10–20 million. Adding that to the first nine months implies approximately $28–38 million for full-year 2026, or roughly a 2% EBITDA margin on expected revenue of $1.5 billion. That is a long way from management's cross-cycle margin target of 13–14%.

### Financial Takeaways

**Free-cash-flow quality:** 2026's positive reported FCF is misleading if treated as recurring. The first nine months produced $100.1 million of operating cash flow and $33.4 million of capital expenditures, but cash inflows included major insurance recoveries, tax refunds, and reductions in working capital. Those sources cannot be repeated indefinitely.

For 2027, management expects maintenance-related expenses around $50 million, compared with $27–29 million in 2026. Capital expenditures are also expected to rise from the reduced 2026 level. This means a rebound in EBITDA may not immediately create a comparable rebound in FCF.

**Financial direction: Deteriorating underlying profitability, with improving liquidity and pricing signals.**

## Management & Capital Allocation

Augusta is the most important company-specific problem.

Management originally believed it was acquiring substantial earnings capacity. In the latest analyst Q&A, management discussed approximately $100 million of EBITDA associated with the acquired business at the time of acquisition expectations. It now attributes a large portion of the shortfall to lower market pricing, but also acknowledged that mill production has been approximately 10–15% below desired performance levels over recent quarters.

This is particularly concerning because the problems extend beyond ordinary cyclical pricing. The company has recovered approximately $73 million from representation-and-warranty insurance. The latest payment completes those recoveries, and management is evaluating its remaining options regarding the transaction.

The key unanswered question is the total cost and time required to make Augusta reliable.

Meanwhile, CLW repurchased approximately $17.2 million of shares during 2025 at an average $28.71 per share—more than twice the current price. That is not, by itself, evidence of poor governance, but it does call for more disciplined capital allocation while asset remediation and liquidity take priority.

CFO Sherri Baker also announced her departure for another opportunity following the Q3 results. The company provided a personal explanation; I would monitor continuity in financial leadership without assuming misconduct.

### Management Takeaway

Management has reduced costs and refinanced maturities, but the Augusta acquisition is far less attractive at current pricing and reliability levels than originally anticipated. Credibility will depend on completing repairs within a defined budget and producing sustainable cash generation rather than relying on one-time proceeds.

## Valuation

### Current Valuation

| Metric | Value |
|---|---:|
| Price Snapshot | $13.40 — 2026-11-03 regular-session close, America/New_York |
| Market Capitalization | ~$221M |
| Enterprise Value | ~$482M, adjusted economic basis |
| Trailing revenue | ~$1.51B |
| Adjusted EV / Sales | ~0.32× |
| Price / Book | ~0.28× |
| FY2026 guided adjusted EV / EBITDA | ~12.7–17.2× |

One important adjustment: some market-data providers currently show enterprise value around $766 million because they count gross debt while excluding restricted cash set aside to redeem the old notes. That temporarily distorts CLW's capital structure during refinancing.

The company reports net debt of $260.7 million after accounting for the restricted redemption cash. The old notes were subsequently redeemed in October. For economic valuation, I therefore use **$221M equity market capitalization + $261M economic net debt = $482M enterprise value**. It is important not to count the redeemed debt without also recognizing the restricted cash funding its repayment.

### Comparable Company Analysis

October 27, 2026 closing-price snapshot. Peer metrics from StockAnalysis/S&P Global Market Intelligence; CLW's enterprise multiples manually adjusted for restricted redemption cash.

| Company | Relevance | Public / Private | EV / Sales | EV / EBITDA | Growth / Margin / Risk Context |
|---|---|---|---:|---:|---|
| **CLW** | Subject; nonintegrated SBS producer | Public | ~0.32× adjusted | ~12.7–17.2× FY2026E adjusted | Deeply depressed earnings; pure-play cycle and Augusta risk |
| Graphic Packaging (GPK) | Direct paperboard competitor, integrated operations | Public | 0.93× | 7.06× | Broader business and converting economics |
| Smurfit Westrock (SW) | Direct paperboard competitor, broad global packaging | Public | 1.14× | 7.82× | Global diversity and much greater scale |
| Georgia-Pacific | Direct industrial competitor | Private | N/A | N/A | Large diversified paper and packaging producer |
| Sappi | Specialty/import competitor | Public | Not comparable on same scope | Not comparable on same scope | Product and geography differences |

**Comparable takeaway:** CLW looks inexpensive on sales and accounting equity, but expensive on depressed earnings. The peers have more diversified assets and substantial converting operations. Their multiples provide context rather than an interchangeable benchmark. The central question is whether CLW can produce substantially more than $30–40 million of annual EBITDA again.

### Valuation Scenarios

I use a year-end 2028 exit-value framework discounted to October 2026 at a 15% required equity return, with approximately 16.14 million shares and scenario-specific ending net debt. These are independent analyst assumptions, not company guidance.

| Scenario | Key Assumptions | Fair Value | Probability | Probability Rationale | Return From Price Snapshot |
|---|---|---:|---:|---|---:|
| **Bear** | 2028 EBITDA $70M, EV/EBITDA 5.0×, net debt $295M; prolonged weak economics | $2.50 | 30% | Augusta problems and cyclicality make a poor outcome material | -81.3% |
| **Base** | 2028 EBITDA $120M, EV/EBITDA 5.75×, net debt $273M; partial recovery | $19.00 | 50% | Pricing and reliability improve but remain below aspirational cycle targets | +41.8% |
| **Bull** | 2028 EBITDA $175M, EV/EBITDA 6.5×, net debt $210M; strong pricing and operations | $42.25 | 20% | Credible operating leverage but execution and timing uncertain | +215.3% |
| **Probability-Weighted** | Weighted present values; exit values discounted ~2.2 years at 15% | **$18.70** | **100%** | High upside skew offset by weak bear case | +39.6% |

The bull case contributes approximately $8.45 of the $18.70 weighted fair value, making the valuation sensitive to whether the upper-end recovery truly materializes.

### Valuation Takeaway

- **Primary valuation method:** Discounted 2028 scenario-specific normalized EBITDA exit enterprise values, less scenario net debt, divided by 16.14M shares.
- **Cross-check methods:** Adjusted EV/Sales, price/book, depressed versus normalized EV/EBITDA, and GPK/SW multiples.
- **Key valuation dependencies:** SBS pricing, Augusta remediation, future maintenance capital and expenses, and organic debt reduction.
- **Valuation confidence / Risk Level:** 35/100 — High.
- **Margin-of-safety conclusion:** Expected return supports only a speculative Buy; bear-case equity downside is approximately 81.7%, and strong downside protection is absent.

Using the approved methodology:

| Zone | Price |
|---|---:|
| Strong Buy | ≤ $2.75 |
| Buy | > $2.75 to $14.96 |
| Hold / Watch | > $14.96 to $20.78 |
| Avoid Chasing Above | $20.78 |

The exceptionally low Strong Buy threshold is intentional. A company with such a weak bear-case valuation cannot receive a high-conviction, downside-protected rating simply because its upside appears large.

## Analyst Questions

The latest call's material Q&A centered on four analyst participants. Multiple questions and follow-ups by the same analyst are consolidated below.

| Analyst / Firm | Core Question | Management Response | Research Read-Through |
|---|---|---|---|
| Mike Roxland / Truist | How quickly can CUK and CRB ramp, what were the Augusta warranty deficiencies, and how large is the debt-service burden? | Management said the new offerings remain early-stage and that certain representations about Augusta assets and contracts were incomplete or inaccurate. Approximately $9.5 million of insurance recoveries offset Q3 disruption losses; annual interest was expected near $25 million. | New-product diversification cannot yet offset core weakness. Q3 adjusted EBITDA includes unusual insurance offset against disruptions, and financing is more costly. |
| Sean Steuart / TD Cowen | Why is 2026 capex below normal, what maintenance is needed in 2027, and how much will refinancing increase interest expense? | Management said Augusta outages delayed some capex and 2027 spending will exceed 2026, potentially above normal maintenance levels. Direct outage expenses could reach about $50 million; annual interest could be closer to $25 million in 2027 than about $20 million in 2026. | Current cash flow benefits from timing. More capital, maintenance expense, and interest will absorb part of pricing gains. |
| George Staphos / Bank of America | What recourse remains for Augusta underperformance, how much of the gap comes from pricing versus operations, and what are the 2027 maintenance and pricing effects? | Management said warranty recovery is complete at about $73 million and other options are under review. Price declines explain the largest Augusta EBITDA gap, with output about 10–15% below desired capability. The first increase may add $50–55 million of 2027 benefit versus 2026; the second could add $30–40 million if fully realized. | Pricing is crucial, but mill repairs remain costly and under-specified. The second increase is not assured and the earnings bridge is conditional. |
| Matthew McKellar / RBC | How will Cypress Bend switch between SBS and CUK, what limits its capacity and economics, and are SG&A savings sustainable? | Cypress Bend has one machine that will switch between SBS and CUK. Lower-cost conversion sacrifices speed and may cost more per ton. Current lower SG&A run rate appears sustainable. | Sensible capital restraint, but new CUK economics are less attractive than with a full conversion. |

**Additional George Staphos follow-up:** Asked why the low-cost $3–5M CUK implementation could replace the previously contemplated ~$60M full solution. Management said the lower-cost route is slower, potentially more costly to run, and capacity-constrained, but a reasonable way to test the market without large investment.

### Analyst-Q&A Takeaway

The most concerning admission is that Augusta will require more work and capital than originally expected. The most encouraging response is that the first $60-per-ton price increase is being realized, with potentially significant carryover into 2027. Neither is sufficient alone to establish the investment case.

## Thesis Monitoring

| Driver | Current State | Positive Trigger / Catalyst | Negative Trigger / Falsifier | What It Changes |
|---|---|---|---|---|
| SBS pricing | First $60 increase being realized; second not fully confirmed | First increase fully realized and second increase confirmed | Price recovery reverses | EBITDA recovery and fair values |
| Augusta | Repeated asset and production problems | Sustained production recovery, quantified repair budget | Repeated outages and escalating repairs | Management confidence, capex, bear probability |
| 2027 EBITDA | 2026 implied EBITDA only ~$28–38M | Progress toward $100M+ despite maintenance | Remains materially below $70M | Base and bull feasibility |
| Cash flow | Recent FCF supported by one-time receipts and working capital | Positive FCF excluding one-time settlements | Persistent cash burn | Debt trajectory, valuation confidence |
| Debt | ~$261M economic net debt, maturities extended | Net debt declines organically | Debt rises despite higher prices | Equity risk and exit equity values |
| CUK/CRB expansion | Early-stage offerings and trials | Profitable converter adoption | Ramp fails or absorbs excessive capital | Long-run growth and moat |

I would especially watch Q1 and Q2 2027. Those periods should help establish whether Augusta repairs are working and how much of the pricing recovery survives higher maintenance costs.

## Quality & Opportunity Scorecards

### Quality Score

| Component | Score | Weight | Weighted Contribution | Evidence |
|---|---:|---:|---:|---|
| Business durability and economics | 55 | 25% | 13.75 | Durable packaging uses but very cyclical margins and capital-intensive mills |
| Moat and competitive position | 50 | 25% | 12.5 | Independent converter positioning offsets weak pricing power and larger rivals |
| Growth runway and durability | 53 | 20% | 10.6 | Mature market; adjacent CUK/CRB opportunities remain early |
| Financial quality and balance sheet | 45 | 15% | 6.75 | Weak recurring FCF, costly maintenance, but longer debt maturities |
| Management, governance and capital allocation | 45 | 15% | 6.75 | Cost cuts/refinancing positive; Augusta and repurchases weigh |
| **Quality Score** | **50.4** | **100%** | **50.4** | Tier C |

- **Quality Tier:** C
- **Speculative override:** None; the risk assessment remains High.

### Opportunity Score

| Component | Raw Input | Normalized Score | Weight | Weighted Contribution |
|---|---:|---:|---:|---:|
| Quality | 50.4 | 50.4 | 30% | 15.1 |
| Probability-weighted upside | +39.6% | 100.0 | 35% | 35.0 |
| Bear-case downside | -81.3% | 0.0 | 20% | 0.0 |
| Risk / valuation confidence | 35/100 | 35.0 | 15% | 5.3 |
| **Opportunity Score** |  | **55.4** | **100%** | **55.4** |

- **Opportunity Rank:** Provisional #30 pending a common-date full-universe refresh.
- **Zone Status:** Buy

## Portfolio Context

- **Tracking tier:** On the Radar
- **Owned:** No
- **Tracking source of truth:** `ontheradar.md`
- **Portfolio source of truth:** `portfolio/holdings.md`
- **Scoring independence:** Ownership, account, share count, position size, and cost basis do not alter Quality Score, Opportunity Score, rank, rating, valuation, or valuation zones.

## Investment Decision History

| Timestamp | Price | Rating | Zone Status | Buy Zone | Strong Buy Zone | Avoid Chasing Above | Base FV | P/W FV | P/W Return | Quality | Opportunity / Rank | Change / Rationale |
|---|---:|---|---|---|---|---|---:|---:|---:|---:|---|---|
| 2026-10-27 16:00 EDT | $13.69 | Buy — High Risk | Buy | > $2.75–$14.96 | ≤ $2.75 | > $20.78 | $19.00 | $18.70 | +36.6% | 50.4 / C | 55.4 / Provisional #30 | Initial analysis after Q3 earnings and severe selloff; paperboard turnaround with high Augusta and cash-flow risk |

---

## Material Sources

| Source | Type | Date / Period | What It Supports |
|---|---|---|---|
| [Clearwater Q3 2026 earnings release](https://ir.clearwaterpaper.com/investors/press-releases/news-details/2026/Clearwater-Paper-Reports-Third-Quarter-2026-Results/default.aspx) | Company IR | 2026-10-26 / Q3 2026 | Latest earnings, cash flow, net debt, price and volume trends, reconciliation |
| [Clearwater FY2025 Form 10-K](https://www.sec.gov/Archives/edgar/data/1441236/000144123626000007/clw-20251231.htm) | Regulatory filing | FY2025 | Business, risk factors, customer concentration, historical financials, Augusta, SBS |
| [Clearwater June 2026 investor presentation](https://s24.q4cdn.com/913789668/files/doc_presentations/2026/Jun/01/CLW-Investor-Presentation-June-2026.pdf) | Company IR | 2026-06 | Capacity, industry structure, market scale, strategy, management targets |
| [Q3 2026 earnings-call transcript](https://stockanalysis.com/stocks/clw/transcripts/717300-q3-2026/) | Earnings-call transcript | 2026-10-26 | Management's outlook, pricing, Augusta issues, complete analyst Q&A |
| [FY2025 earnings release](https://ir.clearwaterpaper.com/investors/press-releases/news-details/2026/Clearwater-Paper-Reports-Fourth-Quarter-and-Year-End-2025-Results/default.aspx) | Company IR | FY2025 | Annual EBITDA, historic comparison, asset reliability and market commentary |
| [CLW statistics](https://stockanalysis.com/stocks/clw/statistics/) | Market data / S&P GMI | 2026-10-27 close | Price, market cap, shares, book value, EV reconciliation |
| [GPK statistics](https://stockanalysis.com/stocks/gpk/statistics/) | Market data / S&P GMI | 2026-10-27 close | Comparable valuation multiples |
| [SW statistics](https://stockanalysis.com/stocks/sw/statistics/) | Market data / S&P GMI | 2026-10-27 close | Comparable valuation multiples |
| [2025 annual report — paperboard and substitute substrates](https://www.sec.gov/Archives/edgar/data/1441236/000144123626000020/a2025clearwaterpaperars.pdf) | Regulatory filing / primary product evidence | FY2025; checked 2026-10-28 | Grade-specific paperboard competition and converter exposure |
| [SEC XBRL company facts — CLW](https://data.sec.gov/api/xbrl/companyfacts/CIK0001441236.json) | Regulatory filing (as tagged) | FY2026, through 2026-09-30 | Current-year standalone-quarter and year-to-date source facts for FCF, SBC, revenue and other reported metrics |